REM Sleep Disorder Linked to Neurocognitive Disorders
the Psychiatry Advisor take:
One sleep disorder, REM behavior disorder, could be a sign of impending neurocognitive disease, including Parkinson's and dementia, say scientists presenting their research at the Society of Nuclear Medicine and Molecular Imaging's 2014 Annual Meeting.
Researchers are not sure why spontaneous and unexplained disturbance in REM sleep should lead to a neurocognitive disease like Parkinson's, but new longitudinal imaging data show a clear correlation between idiopathic REM behavior disorder and dysfunction of the dopamine transporter system involved in a wide range of vital brain functions, including memory and motor control. Dysfunction associated with dopamine in the brain marks the first hints of Parkinson's disease.
"Our SPECT study showed a trend toward decreased dopamine transporter density in the brain and Parkinsonism in the follow-up data of patients with REM sleep disorder who had no previous evidence of neurodegenerative disease," said Hongyoon Choi, MD, a PhD candidate and researcher in the department of molecular medicine and biopharmaceutical sciences at Seoul National University Bundang Hospital, Sungnam, Korea. "To our knowledge, a study looking at a long-term link between the two has never been conducted before."
Sleep disorder linked to development of progressive brain diseases such as Parkinson's
Psychiatry Advisor Articles
- New ADHD Pharmacologic Treatments Needed But Few Are On the Way
- Exploring Diagnostic and Treatment Options for Agitation
- Increased Alzheimer's Disease Risk in Hospital-Treated Patients
- Early Bipolar Depression Response to Lurasidone Treatment
- Alzheimer's Disease Patients May Have Levels of Neuroinflammation
- Sleep Disorders Go Undiagnosed Among Many Black People
- Quetiapine-XR Effective on Depressive Symptoms, Substance Use Disorder
- Sleep Behavior, Irritability May Be an Early Symptom of Alzheimer's Disease
- Metabolic, Endocrine Profiles Examined in Long-term Schizophrenia Therapy
- Adolescents With Schizophrenia Prove Able to Tolerate Lurasidone